Nutriband Inc.
03/28/2024 | Press release | Distributed by Public on 03/28/2024 15:16
Material Event - Form 8-K
Item 3.02. Unregistered Sales of Equity Securities.
The following table sets forth the sales of unregistered securities since the Company's last report filed under this item.
| Date | Title and Amount (1) | Purchaser |
Principal |
Total Offering Price/ |
|||||
| March 20, 2024 | Option to purchase 97,500 shares of common stock. | Gareth Sheridan, Chief Executive Officer | NA | $2.61 per share/NA | |||||
| March 20, 2024 | Option to purchase 97,500 shares of common stock. | Serguei Melnik, President | NA | $2.61 per share/NA | |||||
| March 20, 2024 | Option to purchase 75,000 shares of common stock. | Gerald Goodman, Chief Financial Officer | NA | $2.37 per share/NA | |||||
| March 20, 2024 | Option to purchase 70,000 shares of common stock. | Alan Smith, Chief Operating Officer | NA | $2.37 per share/NA | |||||
| March 20, 2024 | Option to purchase 25,000 shares of common stock. | Jeff Patrick, Chief Scientific Officer | NA | $2.37 per share/NA | |||||
| March 20, 2024 | Option to purchase 2,500 shares of common stock. | Dianna Mather | NA | $2.37 per share/NA | |||||
| March 20, 2024 | Option to purchase 12,500 | Olet Burea, consultant | NA | $2.37 per share/NA | |||||
| Common stock purchase warrant to purchase 15,000 shares of common stock. | Michael Paige, Counsel | NA | $2.37 per share/NA |